Distribution of active pharma R&D projects in the U.S. by therapeutic area 2011
This graph depicts the distribution of active pharmaceutcial R&D projects in the United States in 2011. Oncological R&D projects held more than 30 percent of all active R&D projects. Endocrine therapies only had a five percent share of all active pharma R&D projects.